Integer to build new innovation and manufacturing facility in Galway, Ireland

Expansion to significantly increase Integer’s presence and capabilities in Galway; Means continued growth and a commitment to Integer customers

PLANO, Texas, September 22, 2021 (GLOBE NEWSWIRE) – Integer Holdings Corporation (NYSE: ITGR), a leading manufacturer of medical device outsourcing (MDO), today announced that it will further expand its presence in Galway, Ireland, with the construction of a new medical device manufacturing and innovation facility in the Parkmore East district of Galway. This new facility is required to meet increased demand for regional research, development and manufacturing capacity as well as capacity for catheters and delivery systems. It adds to Integer’s 15 global manufacturing sites and its current presence in Ireland, which includes an R&D center in Galway and manufacturing facilities in Galway and New Ross, County Wexford.

“I am truly delighted to see Integer announce an additional investment in Galway, with the addition of a new medical device manufacturing and innovation facility,” said Tánaiste and the Minister of Trade and Business Employment , Leo Varadkar TD. “I understand that this expansion will translate into 100 to 200 new positions in the years to come, creating excellent employment opportunities for the people of the region. This collaboration between IDA and Integer is another example of the valuable work IDA has done in attracting investment to the country. I wish the team every success in this expansion.

“This expansion once again demonstrates Integer’s commitment to supporting our customers’ growth strategies,” said Payman Khales, President of Integer’s Cardio and Vascular business. “The new Galway facility will allow us to continue our research and development investments in this important medical device center. The significant manufacturing space in the same facility will allow a seamless transition of new products from development to manufacturing, further enabling us to help our customers get their products to market faster – a strategic priority as we move our business forward. vision to improve the lives of patients around the world. “

The initial phase of the project will include the construction of a 60,000 square foot facility on land purchased from IDA Ireland and involves a planned investment of $ 30 million over the next few years. Construction is expected to begin in 2022 and be completed at the end of 2023. Once completed, all new regional research, development and manufacturing activities will be housed in this facility, with investment in equipment continuing over the 2- Next 3 years. This initial phase will meet Integer’s immediate space needs in the region; however, the company has obtained a building permit for a total of 147,000 square feet for future expansion should the need arise.

The story continues

Integer’s presence in Ireland spans over 25 years. Throughout this time, Integer has consistently invested in its infrastructure, technology and associates.

The significant investment announced today continues this trend, while strengthening Integer’s commitment to its operations and customers in Ireland. The company currently employs around 1,300 people in Ireland, of which 350 are in Galway. The addition of the new Galway facility is expected to add around 100-200 engineering, administrative and manufacturing jobs to Integer over the next few years, while the design and construction business is expected to employ several hundred contractors. third in the Galway region. .

“We are excited about our continued growth in Ireland and look forward to meeting the increased needs of our customers in the future,” Khales continued.

“Integer’s planned expansion to Galway is very good news,” said Martin Shanahan, CEO of IDA. “This is an important strategic decision for the company, positioning it to meet the growing demand for its products globally. This is a significant investment from a leading medical device company and demonstrates Integer’s continued commitment to Galway and the Western region. Integer is a valued employer in Ireland where it has access to a highly skilled and talented workforce. I wish the company continued success.

About the whole^®
Integer Holdings Corporation (NYSE: ITGR) is one of the world’s largest contracted medical device (MDO) manufacturers serving the cardiac, neuromodulation, vascular, wearable medical, advanced surgical and orthopedic markets. The company provides innovative, high-quality medical technologies that improve the lives of patients around the world. In addition, it develops batteries for high-end niche applications in the energy, military and environmental markets. Greatbatch medical^®, Lake District Medical^® and Electrochem^® include company brands. Further information is available at www.integer.net.

Forward-looking statements
Certain of the statements contained in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including including statements relating to our expectation of continued compliance with the covenants and the benefits of the amendment. You can identify forward-looking statements by using terms such as “may”, “will”, “should”, “could”, “expects”, “” predicted “,” potential “or” continue “or variations or the negative of these terms or other comparable terminology. These statements are predictions only and actual events or results may differ materially from those stated or implied by such forward-looking statements. In evaluating such statements, you should carefully consider a number of factors, including, but not limited to, risks and uncertainties which arise from time to time and are described in Section 1A “Factors of risk ”in our Annual Report on Form 10-K and in our other periodic SEC filings. Except as required by law, we assume no obligation to update any forward-looking statements contained in this press release, whether to reflect changed assumptions, the occurrence of unforeseen events or changes in the results of future operating, financial conditions or prospects, or otherwise.

Investor Relations
Tony Borowicz
tony.borowicz@integer.net
716.759.5809

Media relations
Kelly butler
kelly.butler@integer.net
214.618.4216